Skip to main content

Daxor Corp

DXR
Exchange
Nasdaq
SEC CIK
0000027367

No open-market purchases or sales by Daxor Corp insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.33M in total; no superinvestor holds it.

Holders of 5% or more of DXR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Daxor Corp, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Daxor Corp on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Daxor Corp, newest first.

No Schedule 13D or 13G filings on Daxor Corp are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Daxor Corp shares.

No Form 144 notices for Daxor Corp are on file.